Basilea secures $76 million senior secured loan to refinance December maturing bonds

0






Newswires MT 2022

All news from BASILEA PHARMACEUTICA AG

2022 sales 109M
111M
111M
2022 net income -26.8M
-27.3M
-27.3M
Net debt 2022 47.8 million
48.6M
48.6M
PER 2022 ratio -17.5x
2022 return
Capitalization 456M
463M
463M
EV / Sales 2022 4.62x
EV / Sales 2023 3.42x
# of employees 177
Floating 88.1%

Chart BASILEA PHARMACEUTICA AG


Duration :

Period :




Basilea Pharmaceutica AG Technical Analysis Chart |  MarketScreener

Trends in technical analysis BASILEA PHARMACEUTICA AG

Short term Middle term Long term
Tendencies Bearish Bullish Neutral




Evolution of the income statement

Sale

To buy

Medium consensus SURPASS
Number of analysts 4
Last closing price CHF38.50
Average target price CHF67.48
Average Spread / Target 75.3%


Share.

Comments are closed.